Several meta-analyses of genome-wide association screens on multiple sclerosis (MS) patients, and healthy controls, demonstrated significant association of single nucleotide polymorphisms correlated with CD6 alternative splicing and MS [59,60,61]. The gene discussed is CD6; the disease is myeloid sarcoma.